Live Analyst Rating Changes 22260 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Lisa De Neve
MS

Lisa De Neve

Morgan Stanley
Wall Street Analyst
★★★☆☆
#977
on 13Foresight · ranked by our own returns
68%
Success Rate
+0.9%
Average Return
19 of 28 calls profitable · -4.6% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 68% of Lisa De Neve's ratings turned a profit when each position was held for 1 year — averaging +0.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

22 Buy 34 Hold 5 Sell
Lisa's Stock Coverage 18 ratings · 2026-08-10
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
IFF
International Flavors & Fragrances
 Aug 06, 2026 BUY Strong Buy
+16.7% avg upside
28 analysts
$100.00
16.35% Upside
 +1.6% ·
GB:CRDA
Croda International
 Jul 29, 2026 BUY Strong Buy
+16.2% avg upside
12 analysts
$3400.00
3.18% Upside
 +0.3% ·
GB:0O7D
Yara International
 Jul 27, 2026 HOLD Buy
+7.4% avg upside
14 analysts
$480.00
14.37% Upside
 · ·
ICL
Icl
 Jul 22, 2026 HOLD Hold
+11.2% avg upside
5 analysts
$5.60
5.40% Upside
 -0.2% ·
FR:AI
Air Liquide
 Jul 20, 2026 BUY Strong Buy
+1.7% avg upside
23 analysts
$206.00
19.34% Upside
 -1.9% ·
FR:AKE
Arkema
 Jul 20, 2026 HOLD Hold
+15.7% avg upside
15 analysts
$63.00
1.40% Upside
 +12.6% ·
GB:0Q4U
Novonesis
 Jul 20, 2026 BUY Strong Buy
+7.2% avg upside
13 analysts
$520.00
21.92% Upside
 · ·
GB:0NZR
Solvay SA
 Jul 20, 2026 SELL Hold
+39.4% avg upside
15 analysts
$23.00
14.45% Downside
 · ·
CH:CLN
Clariant AG
 Jul 20, 2026 SELL Hold
+16.4% avg upside
15 analysts
$7.00
29.67% Downside
 -37.5% ·
NL:DSFIR
DSM-Firmenich AG
 Jun 18, 2026 HOLD Hold
-14.5% avg upside
7 analysts
$73.00
22.41% Downside
 +21.7% ·
DE:SY1
Symrise
 Jun 16, 2026 BUY Strong Buy
+11.0% avg upside
21 analysts
$98.00
6.72% Upside
 +9.6% ·
CH:GIVN
Givaudan SA
 Jun 15, 2026 HOLD Buy
+8.3% avg upside
21 analysts
$2900.00
13.98% Downside
 +6.3% ·
GB:KYGA
Kerry Group plc
 Jun 11, 2026 HOLD Strong Buy
+26.9% avg upside
11 analysts
$88.00
6.66% Upside
 +9.1% ·
GB:TATE
Tate & Lyle
 Apr 01, 2026 SELL Buy
+5.8% avg upside
10 analysts
$375.00
32.12% Downside
 -57.3% ·
DE:SDF
K+S Aktiengesellschaft
 Nov 28, 2025 HOLD Sell
+22.2% avg upside
14 analysts
$12.00
17.31% Downside
 +24.3% ·
DE:WCH
Wacker Chemie AG
 Jul 05, 2024 HOLD Hold
+1.8% avg upside
16 analysts
$128.00
35.79% Upside
 -36.0% ·
NL:OCI
OCI N.V.
 Apr 19, 2024 HOLD Strong Buy
+422.0% avg upside
8 analysts
$27.50
577.92% Upside
 +12.5% ·
DCF
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
 Nov 22, 2023 SELL Buy
+36700.2% avg upside
2 analysts
$3400.33
36700.22% Upside
 · ·
🔒 13 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Lisa De Neve — Frequently Asked Questions
How accurate are Lisa De Neve's stock ratings?
Based on the calls 13Foresight could measure, about 68% of Lisa's ratings were profitable over a one-year hold, with an average return of +0.9% per rating, or -4.6% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Lisa ranked on 13Foresight?
Lisa De Neve is currently ranked #977 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Lisa cover?
Lisa most recently has ratings on IFF, GB:CRDA, GB:0O7D, ICL, FR:AI, FR:AKE, GB:0Q4U, GB:0NZR, CH:CLN, NL:DSFIR, DE:SY1, CH:GIVN and 6 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.